New glycaemic control algorithm for type 2 diabetes

The Australian Diabetes Society has released an updated position statement with an algorithm aimed at demystifying treatment pathways for type 2 diabetes.

The statement introduces GLP-1 receptor agonists and SGLT2-inhibitors that were not available when it was last updated in 2009.

Although its focus on individualisation of glycaemic targets is similar to the previous version, treatment options are presented in a colour-coded chart, with blue boxes indicating usual treatments, white boxes indicating alternative approaches and red borders indicating whether treatments are